Component-resolved microarray analysis of IgE sensitization profiles to Culicoides recombinant allergens in horses with insect bite hypersensitivity.


Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
04 2021
Historique:
revised: 01 07 2020
received: 14 04 2020
accepted: 06 07 2020
pubmed: 12 8 2020
medline: 15 5 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

Allergy to bites of blood-sucking insects, including biting midges, can affect both human and veterinary patients. Horses are often suffering from an IgE-mediated allergic dermatitis caused by bites of midges (Culicoides spp). With the aim to improve allergen immunotherapy (AIT), numerous Culicoides allergens have been produced as recombinant (r-) proteins. This study aimed to test a comprehensive panel of differently expressed Culicoides r-allergens on a cohort of IBH-affected and control horses using an allergen microarray. IgE levels to 27 Culicoides r-allergens, including 8 previously unpublished allergens, of which 11 were expressed in more than one expression system, were determined in sera from 347 horses. ROC analyses were carried out, cut-offs selected using a specificity of 95% and seropositivity rates compared between horses affected with insect bite hypersensitivity (IBH) and control horses. The combination of r-allergens giving the best performing test was determined using logistic regression analysis. Seropositivity was significantly higher in IBH horses compared with controls for 25 r-allergens. Nine Culicoides r-allergens were major allergens for IBH with seven of them binding IgE in sera from > 70% of the IBH-affected horses. Combination of these top seven r-allergens could diagnose > 90% of IBH-affected horses with a specificity of > 95%. Correlation between differently expressed r-allergens was usually high (mean = 0.69, range: 0.28-0.91). This microarray will be a powerful tool for the development of component-resolved, patient-tailored AIT for IBH and could be useful for the study of allergy to biting midges in humans and other species.

Sections du résumé

BACKGROUND
Allergy to bites of blood-sucking insects, including biting midges, can affect both human and veterinary patients. Horses are often suffering from an IgE-mediated allergic dermatitis caused by bites of midges (Culicoides spp). With the aim to improve allergen immunotherapy (AIT), numerous Culicoides allergens have been produced as recombinant (r-) proteins. This study aimed to test a comprehensive panel of differently expressed Culicoides r-allergens on a cohort of IBH-affected and control horses using an allergen microarray.
METHODS
IgE levels to 27 Culicoides r-allergens, including 8 previously unpublished allergens, of which 11 were expressed in more than one expression system, were determined in sera from 347 horses. ROC analyses were carried out, cut-offs selected using a specificity of 95% and seropositivity rates compared between horses affected with insect bite hypersensitivity (IBH) and control horses. The combination of r-allergens giving the best performing test was determined using logistic regression analysis.
RESULTS
Seropositivity was significantly higher in IBH horses compared with controls for 25 r-allergens. Nine Culicoides r-allergens were major allergens for IBH with seven of them binding IgE in sera from > 70% of the IBH-affected horses. Combination of these top seven r-allergens could diagnose > 90% of IBH-affected horses with a specificity of > 95%. Correlation between differently expressed r-allergens was usually high (mean = 0.69, range: 0.28-0.91).
CONCLUSION
This microarray will be a powerful tool for the development of component-resolved, patient-tailored AIT for IBH and could be useful for the study of allergy to biting midges in humans and other species.

Identifiants

pubmed: 32780483
doi: 10.1111/all.14556
pmc: PMC8246938
doi:

Substances chimiques

Allergens 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1147-1157

Informations de copyright

© 2020 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Références

Vet Res. 2006 Nov-Dec;37(6):813-25
pubmed: 16973120
Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):156-70
pubmed: 16574245
Vet Immunol Immunopathol. 2008 Mar 15;122(1-2):126-37
pubmed: 18155778
Parasitol Res. 2009 Aug;105(2):337-44
pubmed: 19340458
Vet Immunol Immunopathol. 1999 Nov 30;71(3-4):307-20
pubmed: 10587309
Exp Parasitol. 1998 Feb;88(2):121-30
pubmed: 9538866
Vet Immunol Immunopathol. 2018 Jul;201:32-37
pubmed: 29914679
Equine Vet J. 1999 Nov;31(6):466-72
pubmed: 10596926
Vet Immunol Immunopathol. 2011 Feb 15;139(2-4):200-9
pubmed: 21071100
Equine Vet J. 1978 Oct;10(4):243-8
pubmed: 738265
Vet Immunol Immunopathol. 2008 Nov 15;126(1-2):102-9
pubmed: 18676025
Allergy. 2019 May;74(5):874-887
pubmed: 30644576
Parasit Vectors. 2018 Mar 27;11(1):217
pubmed: 29587832
Ann Allergy Asthma Immunol. 2017 Sep;119(3):201-209
pubmed: 28890016
Int J Parasitol. 2009 Jan;39(2):243-50
pubmed: 18708061
Vet Immunol Immunopathol. 2013 Jun 15;153(3-4):227-39
pubmed: 23561552
Vet Immunol Immunopathol. 2007 Dec 15;120(3-4):160-7
pubmed: 17888519
Equine Vet J. 1990 Jul;22(4):232-5
pubmed: 2209518
Med Vet Entomol. 2009 Jun;23(2):93-8
pubmed: 19493190
Vet Immunol Immunopathol. 2008 Mar 15;122(1-2):94-103
pubmed: 18068808
Vet Immunol Immunopathol. 2012 Jun 30;147(3-4):113-26
pubmed: 22575371
Clin Exp Allergy. 1999 Jul;29(7):896-904
pubmed: 10383589
Vet Immunol Immunopathol. 2015 Oct 15;167(3-4):171-7
pubmed: 26163936
Vet Dermatol. 2014 Feb;25(1):29-e10
pubmed: 24267396
Sci Rep. 2019 Oct 23;9(1):15170
pubmed: 31645629
J Am Mosq Control Assoc. 2005 Mar;21(1):90-5
pubmed: 15825768
Insect Mol Biol. 2009 Jun;18(3):383-93
pubmed: 19523070
J Immunol Methods. 2012 Aug 31;382(1-2):48-57
pubmed: 22580759
Microb Cell Fact. 2014 Apr 11;13(1):52
pubmed: 24725543
J Vet Med A Physiol Pathol Clin Med. 2006 Feb;53(1):30-3
pubmed: 16411906
Vet Immunol Immunopathol. 2010 Sep 15;137(1-2):76-83
pubmed: 20537727
Equine Vet J. 2006 Jan;38(1):40-6
pubmed: 16411585
Vet Immunol Immunopathol. 2006 Sep 15;113(1-2):99-112
pubmed: 16797724
Acta Vet Scand. 2018 Nov 3;60(1):69
pubmed: 30390694
Vet Immunol Immunopathol. 2008 Dec 15;126(3-4):302-8
pubmed: 18926574
Can Vet J. 1984 Jan;25(1):26-32
pubmed: 17422351
Vet Dermatol. 2015 Dec;26(6):467-75, e108-9
pubmed: 26345148
Equine Vet J. 2001 Nov;33(7):707-13
pubmed: 11770994
Can Vet J. 1988 Sep;29(9):718-23
pubmed: 17423117
J Med Entomol. 1993 Jul;30(4):657-63
pubmed: 8360890
Equine Vet J. 1984 Mar;16(2):117-20
pubmed: 6714213
Vet Immunol Immunopathol. 2015 Feb 15;163(3-4):202-9
pubmed: 25530476
Vet Rec. 1974 Nov 2;95(18):411-5
pubmed: 4451336
Am J Trop Med Hyg. 1997 Sep;57(3):375-81
pubmed: 9311653
Vet Immunol Immunopathol. 2012 Oct 15;149(3-4):245-54
pubmed: 22906994
Vet Parasitol. 1996 Feb;61(3-4):327-38
pubmed: 8720570
PLoS One. 2015 Aug 27;10(8):e0135278
pubmed: 26313909
Vet J. 2014 Apr;200(1):31-7
pubmed: 24703873
Allergy. 2021 Apr;76(4):1147-1157
pubmed: 32780483
Vet Dermatol. 2018 Feb;29(1):51-e22
pubmed: 28980353
Protein Expr Purif. 2005 May;41(1):207-34
pubmed: 15915565
Vet J. 2013 Oct;198(1):141-7
pubmed: 23891138
J Comp Pathol. 1994 Feb;110(2):145-52
pubmed: 8040382

Auteurs

Ella N Novotny (EN)

Department of Clinical Research and VPH, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Samuel J White (SJ)

School of Animal, Rural and Environmental Sciences, Nottingham Trent University, Brackenhurst Campus, Southwell, UK.
School of Biosciences, University of Nottingham, Loughborough, UK.

A Douglas Wilson (AD)

Division of Veterinary Pathology, Infection and Immunity, University of Bristol, Langford, UK.

Sara B Stefánsdóttir (SB)

Institute for Experimental Pathology, Biomedical Center, University of Iceland, Reykjavik, Iceland.

Edwin Tijhaar (E)

Cell Biology and Immunology Group, Wageningen University, Wageningen, The Netherlands.

Sigridur Jonsdóttir (S)

Department of Clinical Research and VPH, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Rebekka Frey (R)

AniCura Norsholms Djursjukhus, Norsholm, Sweden.

Dania Reiche (D)

Boehringer Ingelheim Vetmedica GmbH, Rohrdorf, Germany.

Horst Rose (H)

Boehringer Ingelheim Vetmedica GmbH, Rohrdorf, Germany.

Claudio Rhyner (C)

Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos, Switzerland.

Gertraud Schüpbach-Regula (G)

Department of Clinical Research and VPH, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Sigurbjörg Torsteinsdóttir (S)

Institute for Experimental Pathology, Biomedical Center, University of Iceland, Reykjavik, Iceland.

Marcos Alcocer (M)

School of Biosciences, University of Nottingham, Loughborough, UK.

Eliane Marti (E)

Department of Clinical Research and VPH, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH